What question did this study set out to answer?

This report aims to describe a rare instance of severe multisystem immune-related adverse events in a patient treated with ipilimumab and nivolumab for metastatic melanoma.

July 20, 2026Journal of Community Hospital Internal Medicine PerspectivesOpen Access

Severe Multisystem Toxicity from Combination Ipilimumab and Nivolumab in Metastatic Melanoma: A Case Report

View Full Paper

Ask AI

Bookmark

This report aims to describe a rare instance of severe multisystem immune-related adverse events in a patient treated with ipilimumab and nivolumab for metastatic melanoma.
Case report of a patient with metastatic melanoma treated with combination ipilimumab and nivolumab.
Close monitoring for immune-related adverse events, including hepatitis and ocular toxicity.
Analysis of the patient's clinical progression and response to therapy.
The patient developed severe multisystem immune-related adverse events including hepatitis, cholangitis, ocular toxicity, and neurologic progression.
The case emphasizes the complexity and severity of toxicities associated with dual immune checkpoint blockade.
Vigilant monitoring and early recognition of symptoms were essential for managing these complications.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Case report highlights severe multisystem toxicities from combination therapy in metastatic melanoma, suggesting urgent need for monitoring.

Cite This Study

Amer et al. (2026) studied this question.

synapsesocial.com/papers/6a5dba928bd453d3397abb17 https://doi.org/10.55729/2000-9666.1622

View Full Paper

Ask AI

Bookmark

Implication

Case report highlights severe multisystem toxicities from combination therapy in metastatic melanoma, suggesting urgent need for monitoring.

Severe Multisystem Toxicity from Combination Ipilimumab and Nivolumab in Metastatic Melanoma: A Case Report

Key Points

Discussion

Implication

Cite This Study

Severe Multisystem Toxicity from Combination Ipilimumab and Nivolumab in Metastatic Melanoma: A Case Report

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider